ECHA assessment on the need of further EU regulatory measures for cosmetic substances
Ingredients: CHLORHEXIDINE AND SALTS, O-TOLYL BIGUINIDE

Date of publication: 26/04/2023

On 26 April 2023, the European Chemicals Agency (ECHA) published four reports on the assessment of regulatory needs for four substance groups. Based on currently available information, ECHA concluded that there is a need for further EU regulatory risk management for the substances in the biguanides group.

On 26 April 2023, the European Chemicals Agency (ECHA) published four reports on the assessment of regulatory needs for four substance groups, three of these including substances used in cosmetic products.

An assessment of regulatory needs by ECHA can conclude that regulatory risk management at the EU level is required for a (group of) substance(s) (e.g. harmonised classification and labelling, Candidate List inclusion, restriction) or that no regulatory measures are required at the EU level. The assessment is focused on CMR (carcinogenic, mutagenic, and/or toxic to reproduction), sensitiser, endocrine disruptor, PBT/vPvB or equivalent (e.g. substances being persistent, mobile and toxic) and aquatic toxicity hazard endpoints.

Substances groups

  • Guanidylureas, cyanoguanidines and biguanides
  • Hydroxy and alkoxy phenylketones
  • Rose ketones

The group of Guanidylureas, cyanoguanidines, and biguanides is composed of 7 substances with reported uses in cosmetic products:

  • Chlorhexidine (CAS No 55-56-1), Preservative (Annex V/42)
  • Chlorhexidine Diacetate (CAS No 56-95-1), Antimicrobial, Oral care, Preservative (V/42)
  • Chlorhexidine Dihydrochloride (CAS No 3697-42-5), Antimicrobial, Oral care, Preservative (V/42)
  • Chlorhexidine Digluconate (CAS No 18472-51-0), Antimicrobial, Oral care, Preservative (V/42)
  • Chlorhexidine Diundecylenate (CAS No 1884575-91-0), Antimicrobial, Oral care, Deodorant
  • Polyaminopropyl Biguanide (CAS No 27083-27-8, 32289-58-0), Preservative (Annex V/28)
  • O-Tolyl Biguinide (CAS No 93-69-6), Antioxidant

Based on currently available information, ECHA concluded that there is a need for further EU regulatory risk management for the substances in the biguanides group namely for Chlorhexidine (CAS No 55-56-1) and its four salts (Chlorhexidine Diacetate, Chlorhexidine Dihydrochloride, Chlorhexidine Digluconate, and Chlorhexidine Diundecylenate) as well as O-Tolyl Biguinide (CAS No 93-69-6). Chlorhexidine and its salts are potentially very persistent, very mobile, and potentially aquatic toxic; biguanides have been shown that are likely to be endocrine disruptors in the environment.

For Polyaminopropyl Biguanide (CAS No 27083-27-8, 32289-58-0), there is no need for further EU regulatory risk management.

For the groups of Hydroxy and Alkoxy Phenylketones (9 substances) and Rose Ketones (19 substances), ECHA concluded that, based on currently available information, there is no need for further EU regulatory risk management.

Next steps

The first step is the the identification as Substances of Very High Concern (SVHC), followed by the inclusion in the Candidate List. The REACH restriction is seen as the most appropriate measure to minimize the potential for exposure from their widespread use in consumer products.

Cosmetic products containing substances subject to the REACH restriction list (Annex XVII) due to hazards to the environment, must comply with any REACH restriction requirement. This means that the use of Chlorhexidine and its salts as well as of O-Tolyl Biguinide in cosmetic products may suffer changes in the future.

References:

European Chemicals Agency (ECHA) – Assessment of regulatory needs for the group of Guanidylureas, cyanoguanidines and biguanides, 17 April 2023

European Chemicals Agency (ECHA) – Assessment of regulatory needs for the group of Hydroxy and alkoxy phenylketones, 17 April 2023

European Chemicals Agency (ECHA) – Assessment of regulatory needs for the group of Rose Ketones, 17 April 2023

other REGULATORY UPDATES

SCCS Revision of the Scientific Opinion on Vitamin A

Ingredients: RETINOL, RETINYL PALMITATE, RETINYL ACETATE, RETINYL LINOLEATE, RETINAL

Date of publication: 25/10/2022

The Scientific Committee on Consumer Safety has issued a final version of the Scientific Opinion on Vitamin A, concluding that exposure to Vitamin A derived from cosmetics can be a concern for higher exposure consumers, and since cosmetics alone do not exceed the upper limit the SCCS cannot suggest maximum concentration limits that take into account contributions from other sources.

Read More »

SCCS Final Opinion on the Safety of Triclocarban and Triclosan

Ingredients: TRICLOCARBAN and TRICLOSAN

Date of publication: 25/10/2022

During the plenary meeting on 24-25 October 2022, the Scientific Committee on Consumer Safety (SCCS) presented its final opinion on the safety of Triclocarban and Triclosan as substances with potential endocrine disrupting properties in cosmetic products.

Read More »
Any REGULATORY QUESTION?

Regulation (EU) 2022/692 – OMNIBUS ACT VI – New and Updated Classification of Cosmetic Ingredients

Ingredients: BENZOPHENONE, TEOPHYLLINE, MELAMINE, AZADIRACHTA EXTRACTS, TRIMETHYLOLPROPANE TRIACRYLATE, PENTETIC ACID, PENTASODIUM PENTETATE

Date of publication: 03/05/2022

Date of application: 01/12/2023

The Commission Delegated Regulation (EU) 2022/692 includes new or updated classification for 12 chemicals that may be used as cosmetic ingredients. Seven out of these 12 are now classified as carcinogenic, mutagenic or toxic to reproduction (CMR) and are banned from cosmetic products marketed in the EU.

Read More »

UK Responsible Person Labelling Deadline Extension

RESPONSIBLE PERSON

Date of application: 31/12/2025

The UK Office for Product Safety and Standards (OPSS) have reviewed the requirement to label the product with the UK Responsible Person and have decided to extend this transitional provision for a total period of five years, until 31 December 2025.

Read More »

SCCS Final Opinion on the Safety of Triclocarban and Triclosan

Ingredients: TRICLOCARBAN and TRICLOSAN

Date of publication: 25/10/2022

During the plenary meeting on 24-25 October 2022, the Scientific Committee on Consumer Safety (SCCS) presented its final opinion on the safety of Triclocarban and Triclosan as substances with potential endocrine disrupting properties in cosmetic products.

Read More »